Tag: PBMD

Blue Horseshoe Stocks: PZOO News & Other Updates

Pazoo, Inc. PZOO

We directed our attention at PZOO to start off the week, and so far the stock has put on a good performance. From a low of a penny on Monday we saw a nice move up, and yesterday the stock continued to build a higher base of support.

We witnessed a trading range from .0131 to .0144, a modest 10% intraday move; from our observed low on Monday, that’s registered as a nice 44% intraweek swing.

We’re going to need to keep our eye on PZOO as the week progresses, especially in light of the important news update we received from the company this morning regarding its ongoing expansion into the marijuana testing business (excerpt below).

WHIPPANY, N.J., May 20, 2015 (GLOBE NEWSWIRE) — Pazoo, Inc. (OTC:PZOO), is pleased to announce that wholly-owned subsidiary Harris Lee has gained the exclusive right to operate testing laboratories in the State of Colorado utilizing Steep Hill Labs’ highly-rated testing techniques and methodology.

Colorado is the third state in which Pazoo Inc. subsidiaries have created a license relationship with Steep Hill for their testing technology. Agreements have been established with Steep Hill in Nevada, Oregon and now Colorado. >> FULL PR

PlasmaTech Biopharmaceuticals, Inc. PTBI

PTBI is another call we made on Monday which has also returned a noteworthy two-day performance. It’s one that we had already tracked  over an impressive range earlier this month, and when we rehashed it on Monday, we observed a low of 8.05.

Yesterday the stock pushed its way to a high of 10.83, marking a 35% swing. We want to continue to keep a keen eye on PTBI; this morning’s PR alludes to the granting of Orphan Drug status to a couple of the company’s products by the FDA:

NOHO, Inc. DRNK

DRNK also appeared in yesterday’s premarket report, and we wanted to mention the activity that ensued. After gapping up in the morning, the stock executed a dip-and-rip pattern, coming down to bounce off of a low of .0054 before running back to .0076, providing a chance at up to 41% in intraday gains.

Enviro-Serv, Inc. EVSV

We mentioned EVSV along with MNKD yesterday, and it too made a strong move on the day. From .001 the stock found a subsequent high of .0015 for a nice, round, 50% pop.

Side Note:

We’re going to have an eye on HIHI as well today on the heel of some share reduction news. The company is reducing the outstanding shares by nearly a third, so we’ll be interested to follow the resulting price action. >> VIEW PR

Extended Watchlist:
PBMD, ISR, GNCA, PBY, AVEO

Blue Horseshoe Stocks: Bottom Play Friday

NewLead, Ltd. NEWL

We’ve been tracking NEWL for a long time, waiting for the stock to find support and bounce up off of a bottom, and that appears to have happened now. Since the last time we touched base with this play on April 17th, it had consolidated all the way down from the .20’s to less than a nickel.

Yesterday we saw a surge back into the six cent range, so we want to make note of this stock again today, monitor for higher lows and higher highs, and try to take advantage if NEWL continues to rebound.

Prima BioMed, Ltd. PBMD

Here’s another stock that has been trading at a relative bottom, that just put out FDA fast-track news this morning. PBMD is gapping up into the 1.20’s this morning after its big announcement, so this presents us with an interesting and familiar scenario.

Due to the nature of the fresh PR, and the fact that a large gap-up appears imminent, we’re going to have this play on close watch for a dip-and-rip. For our new readers, this is when a significant event drives a stock to gap up, and the resultant profit-taking drives the price back down. It’s there that we attempt to time the bottom and score quick-strike profits on the bounce. Over the years, this has become one of our favorite methods of obtaining rapid in-and-out gains.

SYDNEY, AUSTRALIA–(Marketwired – May 9, 2014) – Prima BioMed Ltd (ASX: PRR) (NASDAQ: PBMD) (“Prima”) is pleased to announce today that the United States Food and Drug Administration (“FDA”) granted Fast Track Designation to the CVac clinical development program at Prima. This program is intended to improve overall survival in patients with relapsed platinum-sensitive epithelial ovarian cancer who enter a second complete remission. Prima will work closely with the FDA in accelerating its development program for CVac to potentially bring this treatment option to patients in the U.S. >>> FULL PR

OBJ Enterprises, Inc. OBJE

OBJE hit our news scanner this morning, and it caused us to take notice of the chart. The stock has been in a continuous downtrend since early this year, so we’re going to go ahead and put this on bottom-watch.

It’s already trading at its annual lows, we’ll just be monitoring for when it does reach an eventual base, where we’ll be waiting to scoop up cheap shares and play the recovery.

HOUSTON–(BUSINESS WIRE)–OBJ Enterprises, Inc. (OBJE) and partner My Go Games LLC (GO) are proud to announce how its growing portfolio of brands will serve as a catalyst and delivery portal as we prepare for multiple game releases in 2014.

My Go Games and OBJE plan to combine strategies that leverage product placement and established brand networks that utilize social, mobile and online platforms to deliver revenue generating games and product sales channels to a booming marketplace. >>> FULL PR

Side Note:

PBR earnings are slated for release today, which could lead to significant volatility. We’ll still be monitoring the same Calls we’ve tracked all week, while staying ready to switch up our strategy should the need arise, dictated by the nature of the figures.

Extended Watchlist:
PLUG, HNSN, PLCC, UEPS

TSLA Options, CANN & Extended Watchlist

Tesla Motors, Inc. TSLA

It isn’t every day that we make options-trading picks, but when we do, they’re usually pretty accurate. On Wednesday, we floated the idea that the TSLA $165 and $170 Weekly Calls were looking attractive, and priming up for possible breakouts. As you can see on the following charts, that assumption proved to be a good one; both contracts would yield opportunities at multi-bag gains.

The $170 Calls were as low as .50 and hit a high of 3.85, representing a 670% move.

  The $165 Calls traded from a low of 1.55 up to 7.95 on Thursday, an intraday swing of 413%

In order to squeeze added gains from these contracts, we’ll need to see TSLA stock to hold support at or above 168.80, and we’re looking for a break of resistance at 172.70. Pre-market trades are currently going off in the 171.50-range.

Advanced Cannabis Solutions, Inc. CANN

CANN has been very good to us in the short while we’ve been tracking it (1st alert, 01/08, Low of 6.31). We’ve included it in every newsletter since Tuesday, and every day it has bulled its way to new highs. Yesterday, it hit 23.35, marking a rise of 270% from our initial alert, which came just six trading sessions ago.

This has been one cannabis stock that has sustained its trend quite well, even as movement in some of the others has slowed. However, just because the feeding frenzy we witnessed in the first week of the new year has calmed down, that doesn’t mean we’ve taken our eyes off of the sector. We expect pot stocks to continue to be one of the more popular items on the speculative trader’s agenda in 2014.

Sector Side Note: Easton Pharmaceutical, Inc. EAPH – One of the other marijuana stocks we’ve followed, EAPH had consolidated off of its recent big run and yesterday began to bounce. We might see more significant gain opportunities from EAPH if it can hold support above the .008-level.

Extended Watchlist:
ARIA, NIHD, PBMD, ARQL, KONE, EFUT